Want to join the conversation?
$VRTX 2Q15 Call: Through both geographic and label expansion, Vertex has continued to grow the number of patients treated with KALYDECO, resulting in strong revenue growth. With ORKAMBI approval and launch in US, the company has an even greater opportunity to treat more patients, resulting in additional revenue growth.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.